E
Lyell Immunopharma, Inc. LYEL
$0.5854 -$0.0209-3.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 61.00K 63.00K 54.00K 68.00K 130.00K
Total Other Revenue -- -- -- -- --
Total Revenue 61.00K 63.00K 54.00K 68.00K 130.00K
Cost of Revenue -- -- -- -- --
Gross Profit 61.00K 63.00K 54.00K 68.00K 130.00K
SG&A Expenses 52.04M 50.69M 54.42M 61.20M 66.98M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -4.23M -3.87M -3.44M -3.03M -3.23M
Total Operating Expenses 219.41M 216.74M 225.27M 239.66M 246.70M
Operating Income -219.35M -216.68M -225.21M -239.59M -246.57M
Income Before Tax -342.99M -203.99M -210.26M -228.34M -234.63M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -342.99 -203.99 -210.26 -228.34 -234.63
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -342.99M -203.99M -210.26M -228.34M -234.63M
EBIT -219.35M -216.68M -225.21M -239.59M -246.57M
EBITDA -199.72M -197.02M -205.13M -219.34M -226.32M
EPS Basic -1.28 -0.80 -0.83 -0.91 -0.94
Normalized Basic EPS -0.46 -0.47 -0.49 -0.53 -0.69
EPS Diluted -1.28 -0.80 -0.83 -0.91 -0.94
Normalized Diluted EPS -0.46 -0.47 -0.49 -0.53 -0.69
Average Basic Shares Outstanding 1.05B 1.02B 1.01B 1.01B 1.00B
Average Diluted Shares Outstanding 1.05B 1.02B 1.01B 1.01B 1.00B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings